<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58487</article-id><article-id pub-id-type="doi">10.7554/eLife.58487</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>A stepped-wedge randomized trial on the impact of early ART initiation on HIV patients' economic welfare in Eswatini</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-186044"><name><surname>Steinert</surname><given-names>Janina Isabel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7120-0075</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187352"><name><surname>Khan</surname><given-names>Shaukat</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187353"><name><surname>Mlambo</surname><given-names>Khudzie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187354"><name><surname>Walsh</surname><given-names>Fiona J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187355"><name><surname>Mafara</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187356"><name><surname>Lejeune</surname><given-names>Charlotte</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187357"><name><surname>Wong</surname><given-names>Cebele</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187358"><name><surname>Hettema</surname><given-names>Anita</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187359"><name><surname>Ogbouji</surname><given-names>Osondu</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187360"><name><surname>Vollmer</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187365"><name><surname>De Neve</surname><given-names>Jan-Walter</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0090-8249</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187362"><name><surname>Mazibuko</surname><given-names>Sikhathele</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187363"><name><surname>Okello</surname><given-names>Velephi</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100602"><name><surname>Bärnighausen</surname><given-names>Till</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187364"><name><surname>Geldsetzer</surname><given-names>Pascal</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">TUM School of Governance</institution>, <institution>Technical University of Munich</institution>, <addr-line><named-content content-type="city">Munich</named-content></addr-line>, <country>Germany</country></aff><aff id="aff2"><institution>Clinton Health Acccess Initiative</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Duke Global Health Institute</institution>, <institution>Duke University</institution>, <addr-line><named-content content-type="city">Durham</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Development Economics</institution>, <institution>University of Göttingen</institution>, <addr-line><named-content content-type="city">Göttingen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff5"><institution content-type="dept">Medical Faculty and University Hospital, Heidelberg University</institution>, <institution>Heidelberg Institute of Global Health</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff6"><institution>Ministry of Health of the Kingdom of Eswatini</institution>, <addr-line><named-content content-type="city">Mbabane</named-content></addr-line>, <country>Eswatini</country></aff><aff id="aff7"><institution content-type="dept">Institute of Public Health</institution>, <institution>University of Heidelberg</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff8"><institution content-type="dept">Division of Primary Care and Population Health, Department of Medicine</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-165403"><name><surname>Schiffer</surname><given-names>Joshua T</given-names></name><role>Reviewing editor</role><aff><institution>Fred Hutchinson Cancer Research Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>janina.steinert@tum.de</email> (JS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>08</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e58487</elocation-id><history><date date-type="received"><day>01</day><month>05</month><year>2020</year></date><date date-type="accepted"><day>21</day><month>08</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Steinert et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Steinert et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58487-v1.pdf"/><abstract><p><bold><italic>Background:</italic></bold> Since 2015, the World Health Organisation (WHO) recommends immediate initiation of antiretroviral therapy (ART) for all HIV-positive patients. Epidemiological evidence points to important health benefits of immediate ART initiation; however, the policy's economic impact remains unknown. <bold><italic>Methods:</italic></bold> We conducted a stepped-wedge cluster-randomised controlled trial in Eswatini to determine the causal impact of immediate ART initiation on patients' economic welfare. Fourteen healthcare facilities were non-randomly matched in pairs and then randomly allocated to transition from the standard of care (ART eligibility at CD4 counts of &lt; 350 cells/mm3 until September 2016 and &lt;500 cells/mm3 thereafter) to the 'Early Initiation of ART for All' (EAAA) intervention at one of seven timepoints. Patients, healthcare personnel, and outcome assessors remained unblinded. Data was collected via standardised paper-based surveys with HIV-positive, ART-naïve adults who were neither pregnant nor breastfeeding. Outcomes were patients' time use, employment status, household expenditures and household wealth. <bold><italic>Results:</italic></bold> A total sample of 3,019 participants were interviewed over the duration of the study. The mean number of participants approached at each facility and time step varied from 4 to 112 participants. Using mixed-effects negative binomial regressions accounting for time trends and clustering, we found no significant difference between study arms for any economic outcome. Specifically, the EAAA intervention had no significant effect on non-resting time use (RR= 1.00, [CI: 0.96, 1.05, p=0.93]) or income-generating time use (RR= 0.94, [CI: 0.73,1.20, p=0.61]). Employment and household expenditures decreased slightly but not significantly in the EAAA group, with risk ratios of 0.93 [CI: 0.82, 1.04, p=0.21] and 0.92 [CI: 0.79, 1.06, p=0.26], respectively. We also found no significant treatment effect on households' asset ownership and living standards (RR=0.96, [CI 0.92, 1.00, p=0.253]). Lastly, there was no evidence of heterogeneity in effect estimates by patients' sex, age, education, timing of HIV diagnosis and ART initiation. <bold><italic>Conclusions:</italic></bold> Given the neutral effect on patients' economic welfare but positive effects on health, our findings support further investments into scaling-up immediate ART for all HIV patients. <bold><italic>Trial Registration: </italic></bold>ClinicalTrials.gov, NCT02909218 and NCT03789448; ethical approval: Eswatini National Health Service Review Board &amp; Harvard T.H. Chan School of Public Health Review Board.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Dutch Postcode Lottery in the Netherlands</institution></institution-wrap></funding-source><award-id>NA</award-id><principal-award-recipient><name><surname>Bärnighausen</surname><given-names>Till</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005156</institution-id><institution>Alexander von Humboldt-Stiftung</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bärnighausen</surname><given-names>Till</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>the Embassy of the Kingdom of the Netherlands in South Africa/Mozambique</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bärnighausen</surname><given-names>Till</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>British Columbia Centre of Excellence in Canada</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bärnighausen</surname><given-names>Till</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004409</institution-id><institution>Doctors Without Borders</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bärnighausen</surname><given-names>Till</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>National Center for Advancing Translational Sciences of the National Institutes of Health</institution></institution-wrap></funding-source><award-id>Award Number KL2TR003143</award-id><principal-award-recipient><name><surname>Geldsetzer</surname><given-names>Pascal</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Joachim Herz Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Steinert</surname><given-names>Janina Isabel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Ethical approval for this study was obtained from the Eswatini National Health Service Review Board in July 2014 (Reference Number: MH/599C/FWA 000 15267). Respondents gave verbal and written consent before completing the interview and were informed about their right to decline or withdraw their participation at any point in time. The study was further granted an exemption for non-human subjects research from the ethics review board of the Harvard T.H. Chan School of Public Health.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2-4 and all supplementary fogures (Figures S1-S9).</p></sec><supplementary-material><ext-link xlink:href="elife-58487-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>